Still the Great Debate – “Fair Balance” in Direct-to-Consumer Prescription Drug Advertising; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
School of Pharmacy, Philadelphia College of Osteopathic Medicine (PCOM), Suwanee, GA, USA
The above titled paper examined the Food and Drug Administration’s (FDA’s) warning letters and notice of violations (NOV) over a 10-year period. Findings from this content analysis reinforced what has been the primary issue for prescription direct-to-consumer advertising (DTCA) since its beginning, the fair balance of risk and benefit information. As opposed to another analysis in 2026 about this still being an issue, is there anything that can be done to prevent this problem from continuing?
Rollins BL, King KW, Zinkhan G, Perri M. Drug inquiry intent and information seeking behavior: a comparison of non-branded versus branded direct-to-consumer prescription advertisements. Drug Inf J. 2010;44(6):673-683. doi:10.1177/009286151004400603
Rollins BL, King KW, Zinkhan G, Perri M. Non-branded or branded direct-to-consumer prescription drug advertising – which is more effective? Health Mark Q. 2011;28(1):86-98. doi:10.1080/07359683.2011.545337
Bhutada NS, Rollins BL, Perri M. Animation in direct-to-consumer advertising of prescription drugs: impact on consumers. Health Commun. 2016; forthcoming.
Rollins BL, Bhutada NS. Impact of celebrity endorsements in disease-specific direct-to-consumer (DTC) advertisements: an elaboration likelihood model approach. International Journal of Pharmaceutical and Healthcare Marketing. 2014; 8(2):164-177. doi:10.1108/IJPHM-05-2013-0024
Bhutada NS, Rollins BL. Disease-specific direct-to-consumer advertising of pharmaceuticals: An examination of endorser type and gender effects on consumers' attitudes and behaviors. Res Social Adm Pharm. 2015;11(6):891-900. doi: 10.1016/j.sapharm.2015.02.003
Bhutada NS, Rollins BL. Effects of Disease-Specific Direct-to-Consumer Advertising on Medication Adherence. J Am Pharm Assoc (2003). 2015;55:434-437.